EXAS Achieves 66% Growth Model Rating, Indicating Strong Potential
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 27 2025
0mins
Source: NASDAQ.COM
- Growth Model Rating: EXACT SCIENCES CORP (EXAS) achieves a 66% rating based on Partha Mohanram's P/B Growth Investor model, indicating strong fundamentals and valuation that suggest potential for sustained future growth.
- Industry Positioning: As a large-cap growth stock in the Biotechnology & Drugs sector, EXAS's rating above 60% typically signifies a level of market interest, which may attract more investor attention.
- Investment Strategy Background: Mohanram's research challenges traditional growth investing notions by highlighting the potential of low book-to-market stocks, and EXAS's performance aligns with this strategy, potentially offering investors opportunities for excess returns.
- Academic Influence: Partha Mohanram, serving as the John H. Watson Chair in Value Investing at the University of Toronto, provides a fresh perspective through his research, and EXAS's high rating reflects recognition in both academic and investment circles, which may further enhance its market performance.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
